Collegium Pharmaceutical, Inc. Earnings Per Share, Basic and Diluted
Collegium Pharmaceutical, Inc. (COLL) reported Earnings Per Share, Basic and Diluted of -$0.07 per share for the 3-month period ending 2019-12-31, per its 10-K filed 2021-02-25.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-02-25
- Collegium Pharmaceutical, Inc. earnings per share, basic and diluted for the quarter ending 2019-12-31 was -$0.07.
- Collegium Pharmaceutical, Inc. earnings per share, basic and diluted for the quarter ending 2019-09-30 was -$0.18.
- Collegium Pharmaceutical, Inc. earnings per share, basic and diluted for the quarter ending 2019-06-30 was -$0.14.
- Collegium Pharmaceutical, Inc. earnings per share, basic and diluted for the quarter ending 2019-03-31 was -$0.29.
- Collegium Pharmaceutical, Inc. earnings per share, basic and diluted for fiscal 2019 was -$0.68.
- Collegium Pharmaceutical, Inc. earnings per share, basic and diluted for fiscal 2018 was -$1.19.
- Collegium Pharmaceutical, Inc. earnings per share, basic and diluted for fiscal 2017 was -$2.47.
- Collegium Pharmaceutical, Inc. earnings per share, basic and diluted for fiscal 2016 was -$3.88.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$0.07 10-K · filed 2021-02-25 | -$0.68 10-K · filed 2020-02-27 | ||
| 2019-09-30 | -$0.18 10-K · filed 2021-02-25 | -$0.62 10-Q · filed 2019-11-06 | ||
| 2019-06-30 | -$0.14 10-K · filed 2021-02-25 | -$0.43 10-Q · filed 2019-08-07 | ||
| 2019-03-31 | -$0.29 10-K · filed 2021-02-25 | |||
| 2018-12-31 | -$1.19 10-K · filed 2020-02-27 | |||
| 2018-09-30 | -$0.50 10-Q · filed 2019-11-06 | -$1.46 10-Q · filed 2019-11-06 | ||
| 2018-06-30 | -$0.40 10-Q · filed 2019-08-07 | -$0.96 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | -$0.57 10-Q · filed 2019-05-08 | |||
| 2017-12-31 | -$0.54 10-K · filed 2019-02-27 | -$2.47 10-K · filed 2020-02-27 | ||
| 2017-09-30 | -$0.45 10-K · filed 2019-02-27 | -$1.95 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | -$0.72 10-K · filed 2019-02-27 | -$1.50 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | -$0.79 10-K · filed 2019-02-27 | |||
| 2016-12-31 | -$1.02 10-K · filed 2018-03-07 | -$3.88 10-K · filed 2019-02-27 | ||
| 2016-09-30 | -$1.13 10-K · filed 2018-03-07 | -$2.85 10-Q · filed 2017-11-08 | ||
| 2016-06-30 | -$1.05 10-K · filed 2018-03-07 | -$1.73 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | -$0.68 10-K · filed 2018-03-07 | |||
| 2015-12-31 | -$1.48 10-K · filed 2018-03-07 | |||
| 2015-09-30 | -$0.46 10-Q · filed 2016-11-10 | -$0.94 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | -$0.45 10-Q · filed 2016-08-11 | -$0.18 10-Q · filed 2016-08-11 | ||
| 2014-12-31 | -$4.50 10-K · filed 2016-03-18 | -$22.72 10-K · filed 2017-03-10 | ||
| 2014-09-30 | -$7.85 10-K · filed 2016-03-18 | -$18.26 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | -$5.33 10-K · filed 2016-03-18 | -$10.36 10-Q · filed 2015-08-12 | ||
| 2014-03-31 | -$5.03 10-K · filed 2016-03-18 | |||
| 2013-12-31 | -$4.06 10-K · filed 2016-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |